Department of Neurosurgery, University Hospital Essen, Essen, Germany.
Ther Adv Neurol Disord. 2011 Sep;4(5):267-79. doi: 10.1177/1756285611415309.
Intracranial aneurysms (IAs) require deliberately selected treatment strategies as they are incrementally found prior to rupture and deleterious subarachnoid haemorrhage (SAH). Multiple and recurrent aneurysms necessitate both neurointerventionalists and neurosurgeons to optimize aneurysmal occlusion in an interdisciplinary effort. The present study was conducted to condense essential strategies from a single neurovascular centre with regard to the lessons learned.
Medical charts of 321 consecutive patients treated for IAs at our centre from September 2008 until December 2010 were retrospectively analysed for clinical presentation of the aneurysms, multiplicity and treatment pathways. In addition, a selective Medline search was performed.
A total of 321 patients with 492 aneurysms underwent occlusion of their symptomatic aneurysm: 132 (41.1%) individuals were treated surgically, 189 (58.2%) interventionally; 138 patients presented with a SAH, of these 44.2% were clipped and 55.8% were coiled. Aneurysms of the middle cerebral artery were primarily occluded surgically (88), whereas most of the aneurysms of the internal carotid artery and anterior communicating artery (114) were treated endovascularly. Multiple aneurysms (range 2-5 aneurysms/individual) were diagnosed in 98 patients (30.2%). During the study period 12 patients with recurrent aneurysms were allocated to another treatment modality (previously clip to coil and vice versa).
Our data show that successful interdisciplinary occlusion of IAs is based on both neurosurgical and neurointerventional therapy. In particular, multiple and recurrent aneurysms require tailored individual approaches to aneurysmal occlusion. This is achieved by a consequent interdisciplinary pondering of the optimal strategy to occlude IAs in order to prevent SAH.
颅内动脉瘤(IA)需要有针对性地选择治疗策略,因为它们在破裂和有害性蛛网膜下腔出血(SAH)之前逐渐被发现。多发性和复发性动脉瘤需要神经介入医生和神经外科医生共同努力,以优化动脉瘤的闭塞。本研究旨在从单一的神经血管中心总结出基本策略,以吸取经验教训。
回顾性分析 2008 年 9 月至 2010 年 12 月在我们中心接受治疗的 321 例连续患者的病历,以了解动脉瘤的临床表现、多发性和治疗途径。此外,还进行了选择性的 Medline 搜索。
共有 321 例 492 个动脉瘤患者接受了症状性动脉瘤的闭塞治疗:132 例(41.1%)患者接受了手术治疗,189 例(58.2%)患者接受了介入治疗;138 例患者出现了蛛网膜下腔出血,其中 44.2%的患者接受了夹闭治疗,55.8%的患者接受了线圈治疗。大脑中动脉的动脉瘤主要通过手术(88 个)进行闭塞,而颈内动脉和前交通动脉的大多数动脉瘤(114 个)则通过血管内治疗进行治疗。98 例患者(30.2%)被诊断为多发性动脉瘤(范围为 2-5 个动脉瘤/个体)。在研究期间,12 例复发性动脉瘤患者被分配到另一种治疗方式(先前的夹闭改为线圈,反之亦然)。
我们的数据表明,成功的跨学科 IA 闭塞是基于神经外科和神经介入治疗的。特别是,多发性和复发性动脉瘤需要针对个体的方法来进行动脉瘤闭塞。这是通过对闭塞 IA 以预防 SAH 的最佳策略进行一致的跨学科思考来实现的。